Your browser doesn't support javascript.
loading
A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes.
Curtin, Francois; Champion, Bernard; Davoren, Peter; Duke, Sally; Ekinci, Elif I; Gilfillan, Chris; Morbey, Claire; Nathow, Thomas; O'Moore-Sullivan, Trisha; O'Neal, David; Roberts, Adam; Stranks, Stephen; Stuckey, Bronwyn; Vora, Parind; Malpass, Sam; Lloyd, David; Maëstracci-Beard, Nicole; Buffet, Bénédicte; Kornmann, Gabrielle; Bernard, Corinne; Porchet, Hervé; Simpson, Richard.
Afiliação
  • Curtin F; GeNeuro SA, Geneva, Switzerland.
  • Champion B; Division of Clinical Pharmacology and Toxicology, Rue Perret-Gentil, University of Geneva, Geneva, Switzerland.
  • Davoren P; Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Macquarie Park, New South Wales, Australia.
  • Duke S; Gold Coast Hospital, Diabetes and Endocrinology, Southport, Queensland, Australia.
  • Ekinci EI; Department of Diabetes Endocrinology and Metabolism, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Gilfillan C; Department of Medicine, Austin Health and The University of Melbourne, Heidelberg Heights, Victoria, Australia.
  • Morbey C; Eastern Clinical Research Unit, Eastern Health and Monash University, Box Hill, Victoria, Australia.
  • Nathow T; AIM Centre, Merewether, New South Wales, Australia.
  • O'Moore-Sullivan T; Ipswich Research Institute, Ipswich, Queensland, Australia.
  • O'Neal D; Mater Hospital, South Brisbane, Queensland, Australia.
  • Roberts A; St. Vincent's Hospital, Department of Medicine, Fitzroy, Victoria, Australia.
  • Stranks S; Barwon Health, Department of Endocrinology, Geelong, Victoria, Australia.
  • Stuckey B; Southern Adelaide Diabetes & Endocrine Services, Flinders Medical Centre, Bedford Park, South Australia, Australia.
  • Vora P; Keogh Institute for Medical Research, Queen Elizabeth II Medical Centre, Nedlands,, Western Australia, Australia.
  • Malpass S; Division of Medicine, Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia.
  • Lloyd D; Southern Star Research, Gordon, New South Wales, Australia.
  • Maëstracci-Beard N; Southern Star Research, Gordon, New South Wales, Australia.
  • Buffet B; GeNeuro SA, Geneva, Switzerland.
  • Kornmann G; GeNeuro SA, Geneva, Switzerland.
  • Bernard C; GeNeuro SA, Geneva, Switzerland.
  • Porchet H; GeNeuro SA, Geneva, Switzerland.
  • Simpson R; GeNeuro SA, Geneva, Switzerland.
Diabetes Obes Metab ; 22(7): 1111-1121, 2020 07.
Article em En | MEDLINE | ID: mdl-32077207
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retrovirus Endógenos / Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retrovirus Endógenos / Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça